The implant is engineered to offer PER-001’s sustained release, aiming for a “convenient” dosing frequency of every six ...
Vivani Medical Cofounder and CEO Adam Mendelsohn, Ph.D. discusses the company’s first application of the NanoPortal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback